Arcus Biosciences, Inc. (RCUS) Net income 2016–2025
Arcus Biosciences, Inc. (RCUS) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$353.0MFY2025 · since FY2016: -$18.0M → -$353.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$353.0M | -24.7% |
| FY2024 | -$283.0M | +7.8% |
| FY2023 | -$307.0M | -15.0% |
| FY2022 | -$267.0M | -603.8% |
| FY2021 | $53.0M | +143.1% |
| FY2020 | -$123.0M | -45.2% |
| FY2019 | -$84.7M | -70.8% |
| FY2018 | -$49.6M | +6.6% |
| FY2017 | -$53.1M | -195.4% |
| FY2016 | -$18.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More RCUS financial trends
RCUS RevenueRCUS Net marginRCUS Gross profitRCUS Gross marginRCUS Operating incomeRCUS Operating marginRCUS Operating cash flowRCUS Free cash flowRCUS Capital expendituresRCUS Return on equityRCUS Stock buybacksRCUS Dividends paidRCUS Total assetsRCUS Total liabilitiesRCUS Shareholders’ equityRCUS overview →